-
Mashup Score: 0The CoVID‐TE risk assessment model for venous thromboembolism in hospitalized patients with cancer and COVID‐19 - 7 month(s) ago
Background Hospitalized patients with COVID-19 have increased risks of venous (VTE) and arterial thromboembolism (ATE). Active cancer diagnosis and treatment are well-known risk factors; however, a …
Source: onlinelibrary.wiley.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 10The CoVID‐TE risk assessment model for venous thromboembolism in hospitalized patients with cancer and COVID‐19 - 8 month(s) ago
Background Hospitalized patients with COVID-19 have increased risks of venous (VTE) and arterial thromboembolism (ATE). Active cancer diagnosis and treatment are well-known risk factors; however, a …
Source: onlinelibrary.wiley.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 1Cancer, more than a “COVID-19 co-morbidity” - 1 year(s) ago
Patients with cancer represent a particularly vulnerable population at risk of adverse outcomes related to COVID-19. Collectively, the initial studies, including patients with and without cancer, confirmed that patients with cancer had a higher risk of complications and death related to COVID-19. Subsequent studies on patients with COVID-19 and cancer investigated patient and disease-related…
Source: FrontiersCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0JCI - The convalescent sera option for containing COVID-19 - 2 year(s) ago
To deploy convalescent serum administration for COVID-19 the following six conditions must be met: (i) availability of a population of donors who have recovered from the disease and can donate convalescent serum; (ii) blood banking facilities to process the serum donations; (iii) availability of assays, including serological assays, to detect SARS-CoV-2 in serum and virological assays to measure…
Source: www.jci.orgCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 5
Age is a risk factor for SARS-CoV-2 infection and severe disease. Here the authors perform DNA methylation analyses in whole blood from COVID-19 patients using established epigenetic clocks and telomere length estimators, and describing correlations between epigenetic aging and the risk of SARS-CoV-2 infection and severe disease.
Source: NatureCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 2
Age is a risk factor for SARS-CoV-2 infection and severe disease. Here the authors perform DNA methylation analyses in whole blood from COVID-19 patients using established epigenetic clocks and telomere length estimators, and describing correlations between epigenetic aging and the risk of SARS-CoV-2 infection and severe disease.
Source: NatureCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0
Correspondence from The New England Journal of Medicine — Viral Dynamics of SARS-CoV-2 Variants in Vaccinated and Unvaccinated Persons
Source: New England Journal of MedicineCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0JCI - The convalescent sera option for containing COVID-19 - 2 year(s) ago
To deploy convalescent serum administration for COVID-19 the following six conditions must be met: (i) availability of a population of donors who have recovered from the disease and can donate convalescent serum; (ii) blood banking facilities to process the serum donations; (iii) availability of assays, including serological assays, to detect SARS-CoV-2 in serum and virological assays to measure…
Source: www.jci.orgCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 1Possible coronavirus treatment could be in clinical trials within weeks, using plasma from recovered patients, if doctors get FDA approval - 2 year(s) ago
Doctors have been discussing ways of collaborating to launch clinical trials of what appears to be the most immediate hope for treating COVID-19.
Source: Milwaukee Journal SentinelCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 2
Scientists in Shanghai say some recovered patients show no signs of the neutralising proteins.
Source: South China Morning PostCategories: Hem/Oncs, Latest HeadlinesTweet
The CoVID-TE Risk Assessment Model for Venous Thromboembolism in Hospitalized Patients with Cancer and COVID-19 [Jul 14, 2021] @AngLi_MD et al. @RosovskyRachel @COVID19nCCC @JTHjournal https://t.co/MjGaZvfrrW #VTE #2019nCoV #COVID19 #CCC19 https://t.co/QMlV6R3oov